Literature DB >> 14740117

[Reconstruction of the frontal sinus with a calvarium split galea periosteum transplant after inflammatory complications].

T Grundmann1, W Kehrl.   

Abstract

After reconstruction of the frontal sinus with alloplastic material, with or without obliteration of the lumen, inflammatory complications may occur. The authors present a plastic-surgical functional reconstruction technique for revision surgery in cases of inflammatory complications following frontal sinus implantation of alloplastic material, by means of a modified autologous calvarian split graft. The inflammatory complications after primary reconstruction or obliteration of the frontal sinus occurred after a period of 1-10 years. The previously implanted material was removed from the frontal sinus and the anterior wall was reconstructed with a combined calvarian split/galea periost-transplant. During follow-up, which ranged from 1-5 years, no further inflammatory complications occurred. Furthermore, an appealing cosmetic result was achieved in all cases. We conclude that the functional and aesthetic result depends primarily on (1) embedding and protection of the graft by an additional covering with a galea-periost-flap, and (2) reconstruction of the frontal drainage pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740117     DOI: 10.1007/s00106-003-0840-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  26 in total

1.  Cranioplasty with split-thickness calvarial bone.

Authors:  A Inoue; S Satoh; K Sekiguchi; Y Ibuchi; S Katoh; K Ota; S Fujimori
Journal:  Neurol Med Chir (Tokyo)       Date:  1995-11       Impact factor: 1.742

2.  Repair of large defect of frontal bone with free graft of outer table of parietal bones.

Authors:  J M Psillakis; V L Nocchi; S A Zanini
Journal:  Plast Reconstr Surg       Date:  1979-12       Impact factor: 4.730

3.  The fate of patients with methyl methacrylate cranioplasty.

Authors:  M E Cabanela; M B Coventry; C S MacCarty; W E Miller
Journal:  J Bone Joint Surg Am       Date:  1972-03       Impact factor: 5.284

4.  [Personal experience with Ionocem in head- and neck surgery].

Authors:  J Thallemer; W Draf
Journal:  HNO       Date:  1993-02       Impact factor: 1.284

5.  The influence of the recipient site on bone grafts to the face.

Authors:  J E Zins; J F Kusiak; L A Whitaker; D H Enlow
Journal:  Plast Reconstr Surg       Date:  1984-03       Impact factor: 4.730

6.  Frontal sinus disease. III. Experimental and clinical factors in failure of the frontal osteoplastic operation.

Authors:  N L Schenck
Journal:  Laryngoscope       Date:  1975-01       Impact factor: 3.325

7.  Reshaping of the skull in the early surgical correction of scaphocephaly.

Authors:  R Roddi; J M Vaandrager; P M Gilbert; J C van der Meulen
Journal:  J Craniomaxillofac Surg       Date:  1993-09       Impact factor: 2.078

8.  Cranioplasty with Palacos R in reconstruction of frontal sinus defects.

Authors:  W Mann; A A el-Khatieb
Journal:  J Laryngol Otol       Date:  1988-09       Impact factor: 1.469

9.  The skull as a bone graft donor site.

Authors:  I T Jackson; C Pellett; J M Smith
Journal:  Ann Plast Surg       Date:  1983-12       Impact factor: 1.539

10.  Membranous versus endochondral bone: implications for craniofacial reconstruction.

Authors:  J E Zins; L A Whitaker
Journal:  Plast Reconstr Surg       Date:  1983-12       Impact factor: 4.730

View more
  2 in total

1.  Vascularised local and free flaps in anterior skull base reconstruction.

Authors:  Thomas K Hoffmann; Nicolai El Hindy; Oliver M Müller; Patrick J Schuler; Christoph Bergmann; Robert Hierner; Götz Lehnerdt; Stefan Mattheis; Martin Wagenmann; Jörg Schipper; Ulrich Sure; Stephan Lang; Daniel Hänggi; I Erol Sandalcioglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-10       Impact factor: 2.503

2.  [Orbital stabilisation with suprabrow myofascial transposition flaps].

Authors:  T Grundmann; U Schaudig
Journal:  HNO       Date:  2005-04       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.